D&D Pharmatech is a clinical-stage global biotech company founded and guided by top-tier medical research faculty.As the parent company of US-based Neuraly, Precision Molecular, Valted Seq and P4 Microbiome, D&D funds the development of revolutionary medicines through disease-specific subsidiary companies. This corporate structure creates a unique opportunity to accelerate translation of cutting-edge research into lifesaving therapeutic products for patients. D&D Pharmatech’s clinical portfolio includes GLP-1 based treatments for metabolic diseases such as obesity and NASH, as well as candidates for the treatment of various neurodegenerative diseases and fibrotic diseases. In addition, we are focusing on application of big data in CNS drug research and development of imaging biomarkers and theragnostic.

OralLink : Platform technology for improving oral bioavailability of Peptide

Public

Biotech